Cargando…

Cinchonine, a Potential Oral Small-Molecule Glucagon-Like Peptide-1 Receptor Agonist, Lowers Blood Glucose and Ameliorates Non-Alcoholic Steatohepatitis

PURPOSE: The glucagon-like peptide-1 receptor (GLP-1R) is an effective therapeutic target for type 2 diabetes mellitus (T2DM) and non-alcoholic steatohepatitis (NASH). Research has focused on small-molecule GLP-1R agonists because of their ease of use in oral formulations and improved patient compli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xue, Huan, Xing, Hao-Jie, Wang, Bin, Fu, Chao, Zhang, Yu-Shan, Qiao, Xi, Guo, Chao, Zhang, Xiao-Li, Hu, Bin, Zhao, Xin, Deng, Li-Jiao, Zhu, Xiao-Chan, Zhang, Yi, Liu, Yun-Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184894/ https://www.ncbi.nlm.nih.gov/pubmed/37197367 http://dx.doi.org/10.2147/DDDT.S404055

Ejemplares similares

Sulphate of Cinchonine
Publicado: (1826)

Curious Symptoms Following the Administration of Cinchonine
por: Carey, W.
Publicado: (1877)

Inhibition of Porcine Epidemic Diarrhea Virus by Cinchonine via Inducing Cellular Autophagy
por: Ren, Jingping, et al.
Publicado: (2022)

Report on the Action of Quinodine and Cinchonine, as Regards Their Influence on Malarious Fevers
por: Hamilton, J. Butler
Publicado: (1871)

The A3 adenosine receptor agonist, namodenoson, ameliorates non-alcoholic steatohepatitis in mice
por: Fishman, Pnina, et al.
Publicado: (2019)

Role of Glucagon-Like Peptide-1 Receptor Agonists in the Management of Non-Alcoholic Steatohepatitis: A Clinical Review Article
por: Ghazanfar, Haider, et al.
Publicado: (2021)

Cinchonine induces apoptosis of HeLa and A549 cells through targeting TRAF6
por: Qi, Yonghao, et al.
Publicado: (2017)

Second Series of 25 Cases of Malaria Treated by Hypodermic Injections of Cinchonine Bi-Hydrochloride
por: Ollenbach, D. S.
Publicado: (1920)

An Essay upon Cinchonin, and Its Influence upon the Virtue of Peruvian Bark, and Other Barks
por: Gomes, Bernardinus Anthony
Publicado: (1811)

Blood-stage antiplasmodial activity and oocyst formation-blockage of metallo copper-cinchonine complex
por: Morais, Camila Martins Gomes, et al.
Publicado: (2022)

Association of glucagon‐like peptide‐1 receptor‐targeted imaging probe with in vivo glucagon‐like peptide‐1 receptor agonist glucose‐lowering effects
por: Murakami, Takaaki, et al.
Publicado: (2020)

Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis
por: Armstrong, Matthew J., et al.
Publicado: (2016)

Effects of ALT-801, a GLP-1 and glucagon receptor dual agonist, in a translational mouse model of non-alcoholic steatohepatitis
por: Nestor, John J., et al.
Publicado: (2022)

Cinchonine Prevents High-Fat-Diet-Induced Obesity through Downregulation of Adipogenesis and Adipose Inflammation
por: Jung, Sung A., et al.
Publicado: (2012)

Berberine ameliorates non-alcoholic steatohepatitis in ApoE(−/−) mice
por: Yang, Jin, et al.
Publicado: (2017)

Glucagon-Like Peptide-1 Receptor Agonist Liraglutide Ameliorates the Development of Periodontitis
por: Sawada, Noritaka, et al.
Publicado: (2020)

Review article: role of glucagon‐like peptide‐1 receptor agonists in non‐alcoholic steatohepatitis, obesity and diabetes—what hepatologists need to know
por: Barritt, A. Sidney, et al.
Publicado: (2022)

The Insulin:Glucagon Ratio and the Choice of Glucose-Lowering Drugs
por: Kalra, Sanjay, et al.
Publicado: (2016)

Glucagon-Like Peptide-1 Receptor Agonist Prevented the Progression of Hepatocellular Carcinoma in a Mouse Model of Nonalcoholic Steatohepatitis
por: Kojima, Motoyasu, et al.
Publicado: (2020)

A Glucagon-Like Peptide-1 Receptor Agonist Lowers Weight by Modulating the Structure of Gut Microbiota
por: Zhao, Li, et al.
Publicado: (2018)

Amelioration of muscle wasting by glucagon‐like peptide‐1 receptor agonist in muscle atrophy
por: Hong, Yeonhee, et al.
Publicado: (2019)

Tocopheryl quinone improves non-alcoholic steatohepatitis (NASH) associated dysmetabolism of glucose and lipids by upregulating the expression of glucagon-like peptide 1 (GLP-1) via restoring the balance of intestinal flora in rats
por: Sun, Tao, et al.
Publicado: (2021)

Novel Small Molecule Glucagon-Like Peptide-1 Receptor Agonist S6 Stimulates Insulin Secretion From Rat Islets
por: Yang, Xiaohua, et al.
Publicado: (2021)

Artemether Ameliorates Non-Alcoholic Steatohepatitis by Repressing Lipogenesis, Inflammation, and Fibrosis in Mice
por: Xu, Jia, et al.
Publicado: (2022)

Colesevelam ameliorates non-alcoholic steatohepatitis and obesity in mice
por: Hartmann, Phillipp, et al.
Publicado: (2022)

A Small-Molecule Oral Agonist of the Human Glucagon-like Peptide-1 Receptor
por: Griffith, David A., et al.
Publicado: (2022)

Molecular Characterization of the RNA-Binding Protein Quaking-a in Megalobrama amblycephala: Response to High-Carbohydrate Feeding and Glucose/Insulin/Glucagon Treatment
por: Shi, Hua-Juan, et al.
Publicado: (2018)

Disruption of the glucagon receptor increases glucagon expression beyond α-cell hyperplasia in zebrafish
por: Kang, Qi, et al.
Publicado: (2022)

Higher consumption of animal organ meat is associated with a lower prevalence of nonalcoholic steatohepatitis
por: Zhang, Rui, et al.
Publicado: (2022)

A novel GLP-1 and FGF21 dual agonist has therapeutic potential for diabetes and non-alcoholic steatohepatitis
por: Pan, Qi, et al.
Publicado: (2021)

Conformation Transition of Intracellular Part of Glucagon Receptor in Complex With Agonist Glucagon by Conventional and Accelerated Molecular Dynamics Simulations
por: Bai, Qifeng, et al.
Publicado: (2019)

High glucose promotes the progression of colorectal cancer by activating the BMP4 signaling and inhibited by glucagon-like peptide-1 receptor agonist
por: Ma, Bingwei, et al.
Publicado: (2023)

Effects of glucagon-like peptide-1 receptor agonists on glucose excursion and inflammation in overweight or obese type 2 diabetic patients
por: Huang, Xiao-Min, et al.
Publicado: (2023)

Glucagon-like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes in Youth
por: Berman, Casey, et al.
Publicado: (2023)

Glucagon-Like Peptide-1 Receptor Agonist and Glucagon Increase Glucose-Stimulated Insulin Secretion in Beta Cells via Distinct Adenylyl Cyclases
por: Lee, Young-Sun, et al.
Publicado: (2018)

Magnitude of slowing gastric emptying by glucagon‐like peptide‐1 receptor agonists determines the amelioration of postprandial glucose excursion in Japanese patients with type 2 diabetes
por: Suganuma, Yumi, et al.
Publicado: (2019)

PPAR-alpha/gamma agonists, glucagon-like peptide-1 receptor agonists and metformin for non-alcoholic fatty liver disease: A network meta-analysis
por: Zhang, Zhuo-Ya, et al.
Publicado: (2023)

Structural Modeling and in Silico Screening of Potential Small-Molecule Allosteric Agonists of a Glucagon-like Peptide 1 Receptor
por: Redij, Tejashree, et al.
Publicado: (2019)

Impact of glucose tolerance on the severity of non‐alcoholic steatohepatitis
por: Nakamura, Akinobu, et al.
Publicado: (2011)

Analysis of long noncoding RNA-associated competing endogenous RNA network in glucagon-like peptide-1 receptor agonist-mediated protection in β cells
por: Cui, Li-Juan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_a7ncvp56cp4ljdjgd6p852l5j4